NCT06457256

Brief Summary

Neurodevelopmental disorders of Attention-Deficit/ Hyperactivity Disorder (ADHD) and Oppositional Defiant Disorder (ODD) are extremely common but underserved with Evidence- Based Treatments (EBT) worldwide. Thus, a school clinician training and ADHD/ODD intervention (i.e., the Collaborative Life Skills \[CLS\] program) was developed, implemented and evaluated for Mexico: a setting with high unmet need. Technology was integrated into the in-person program (CLS-FUERTE) to create a digitally enhanced version (CLS-R-FUERTE). Given findings demonstrating feasibility, acceptability, and efficacy of both program versions, a Type 2 Hybrid Effectiveness-Implementation Design will be applied to evaluate the program effectiveness, mechanisms of intervention change, and maintenance barriers/facilitators in a scaled-up cluster randomized controlled trial across two Mexican states -while simultaneously exploring an implementation strategy in which the program is adapted to enhance maintenance given each school's needs/resources (i.e., CLS-A-FUERTE). The implementation process is guided by the Exploration, Preparation, Implementation, and Sustainment (EPIS) model with evaluation following the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) Framework.

Trial Health

78
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
872

participants targeted

Target at P75+ for not_applicable

Timeline
35mo left

Started Oct 2024

Longer than P75 for not_applicable

Geographic Reach
2 countries

3 active sites

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress38%
Oct 2024Jun 2029

First Submitted

Initial submission to the registry

June 7, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 13, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

October 16, 2024

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2029

Last Updated

August 21, 2025

Status Verified

August 1, 2025

Enrollment Period

4.7 years

First QC Date

June 7, 2024

Last Update Submit

August 15, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Child Symptom Inventory-4 (CSI-4) Parent Checklist ADHD Combined type Symptom Severity Score

    Parents will assess ADHD symptoms using the CSI-4. The CSI-4: Parent Checklist contains 18 symptoms for ADHD, Combined type (ADHD:C; 18 items). Each symptom is rated on a 4-point scale (0= never to 3= very often). The average of ADHD:C scores range from zero to four, with higher scores indicating more severe symptoms.

    Baseline and post treatment (8 weeks) and follow-up (3 months)

  • Change in Child Symptom Inventory-4 (CSI-4) Teacher Checklist ADHD Combined type Symptom Severity Score

    Teachers will assess ADHD symptoms using the CSI-4. The CSI-4: Teacher Checklist contains 18 symptoms for ADHD, Combined type (ADHD:C; 18 items). Each symptom is rated on a 4-point scale (0= never to 3= very often). The average of ADHD:C scores range from zero to four, with higher scores indicating more severe symptoms.

    Baseline and post treatment (8 weeks) and follow-up (3 months)

Secondary Outcomes (4)

  • Change in Child Symptom Inventory-4 (CSI-4) Parent Checklist (Oppositional Defiant Disorder) ODD Symptom Severity Score

    Baseline and post treatment (8 weeks) and follow-up (3 months)

  • Change in Child Symptom Inventory-4 (CSI-4) Teacher Checklist (Oppositional Defiant Disorder) ODD Symptom Severity Score

    Baseline and post treatment (8 weeks) and follow-up (3 months)

  • Change Impairment Rating Scale (IRS) Parent Questionnaire Overall Severity Score

    Baseline and post treatment (8 weeks) and follow-up (3 months)

  • Change Impairment Rating Scale (IRS) Teacher Questionnaire Overall Severity Score

    Baseline and post treatment (8 weeks) and follow-up (3 months)

Study Arms (2)

CLS-A-FUERTE

EXPERIMENTAL

Receiving the CLS-A-FUERTE program immediately

Behavioral: CLS-A-FUERTE

School Services as Usual (SA)

NO INTERVENTION

Receiving School Services as Usual while waiting to receive the CLS-A-FUERTE program in the subsequent schoolyear

Interventions

CLS-A-FUERTEBEHAVIORAL

CLS-A-FUERTE Intervention Description: The CLS-A-FUERTE program is a school clinician training and psychosocial intervention program designed to improve attention and behavior in Mexican school-aged youth (grades 1-5). Participating school clinicians are supported by a clinical research team of trainers who co-leads weekly training/consultation meetings and observes each intervention component (i.e., 6 weekly parent and student skills groups, as well as classroom management in the form of a Daily Report Card) in-vivo via videoconferencing.

CLS-A-FUERTE

Eligibility Criteria

Age5 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • must demonstrate at least six inattention symptoms and/or six hyperactive/impulsive symptoms endorsed by parent or teacher as occurring often or very often, AND at least one area of impairment rated as concerning by both parent and teacher, AND have a parent and teacher agreeing to participate (for student participants)
  • Must be a parents, teacher, or school clinicians of participating students (for parent, teacher, and school clinician participants)
  • Must be a university student in psychology or education at UAS or BUAP (for emerging investigator/university student participants)

You may not qualify if:

  • inability to speak and read Spanish
  • unstable medication regimen (for student participants)
  • severe visual or hearing impairment (for student participants)
  • severe language delay (for student participants)
  • psychosis (for student participants)
  • Placement in an all-day special education classroom (for student participants)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

UCSF

San Francisco, California, 94104, United States

Location

Benemérita Universidad Autónoma de Puebla

Puebla City, Puebla, 72000, Mexico

Location

Universidad Autonoma de Sinaloa

Culiacán, Sinaloa, 80050, Mexico

Location

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

  • Lauren Haack, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: School Services as Usual (SAU) waitlist design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2024

First Posted

June 13, 2024

Study Start

October 16, 2024

Primary Completion (Estimated)

June 30, 2029

Study Completion (Estimated)

June 30, 2029

Last Updated

August 21, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations